C-R1C8Retrotope
lipid peroxidation, stabilized PUFAs
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-R1C8
C-R1C8C-R1C8lipid peroxidation, stabilized PUFAs
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Retrotope lipid peroxidation, stabilized PUFAs
Retrotope is developing a pipeline of proprietary therapeutics for degenerative diseases by down-regulating lipid peroxidation to protect against cellular degeneration. Its mission describes first-in-class therapies for orphan neurodegenerative indications and larger degenerative conditions with few or no treatment options. The pipeline includes RT001 for INAD, Friedreich's ataxia, ALS, and PSP, and RT011 for Dry AMD and geographic atrophy.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Retrotope — Far from goals · Lower middle. Derived deterministically from 5 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (4 programs at undisclosed).…
Source: Deterministic